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Abstract
Background: Health inequity is an important issue all around the world. The Chinese basic medical security system
comprises three major insurance schemes, namely the Urban Employee Basic Medical Insurance (UEBMI), the Urban
Resident Basic Medical Insurance (URBMI), and the New Cooperative Medical Scheme (NCMS). Little research has
been conducted to look into the disparity in payments among the health insurance schemes in China. In this study,
we aimed to evaluate the disparity in reimbursements for tuberculosis (TB) care among the abovementioned health
insurance schemes.
Methods: This study uses a World Health Organization (WHO) framework to analyze the disparities and equity
relating to the three dimensions of health insurance: population coverage, the range of services covered, and the
extent to which costs are covered. Each of the health insurance scheme’s policies were categorized and analyzed.
An analysis of the claims database of all hospitalizations reimbursed from 2010 to 2012 in three counties of Yichang
city (YC), which included 1506 discharges, was conducted to identify the differences in reimbursement rates and
out-of-pocket (OOP) expenses among the health insurance schemes.
Results: Tuberculosis patients had various inpatient expenses depending on which scheme they were covered by
(TB patients covered by the NCMS have less inpatient expenses than those who were covered by the URBMI, who
have less inpatient expenses than those covered by the UEBMI). We found a significant horizontal inequity of
healthcare utilization among the lower socioeconomic groups. In terms of financial inequity, TB patients who
earned less paid more. The NCMS provides modest financial protection, based on income. Overall, TB patients
from lower socioeconomic groups were the most vulnerable.
Conclusion: There are large disparities in reimbursement for TB care among the three health insurance schemes and
this, in turn, hampers TB control. Reducing the gap in health outcomes between the three health insurance schemes in
China should be a focus of TB care and control. Achieving equity through integrated policies that avoid discrimination
is likely to be effective.
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Background
China’s health care system is bifurcated in nature between
rural and urban areas [1, 2]. There are three major
government-led complementary insurance schemes col-
lectively known as the Chinese basic medical security
system. The schemes are the Urban Employee Basic
Medical Insurance (UEBMI), the Urban Resident Basic
Medical Insurance (URBMI), and the New Cooperative
Medical Scheme (NCMS) [3, 4]. The UEBMI-established
in 1998 and designed exclusively for urban workers, in-
cluding both public and private sector employees, and
retirees-is a mandatory scheme based on cost sharing
between employers and employees, with risk pooling
managed at the city level [5]. The URBMI, which was
introduced in 2007, is for urban residents without formal
employment who are not covered by the UEBMI (e.g.,
students, young children, the elderly, disabled and other
unemployed urban residents), and is co-financed by those
who use it and the local government. It is managed at
multiple levels. The NCMS is a voluntary program de-
signed to deal with catastrophic illnesses at the county
level. It is based on cost sharing between the government
and farmers, and aims to improve access to health insur-
ance for the rural population [6, 7]. Counties determine
benefit packages and administrative arrangements accord-
ing to their local conditions. The NCMS was piloted in
2003 and has been expanded to 2566 participating coun-
ties, covering 98.3 % of the target population, in 2012.
The source and level of financing for the three health
insurance schemes are different, thus resulting in differ-
ent reimbursement levels and anti-risk capacity. For the
UEBMI, the annual premium is made up of 8 % of
employees’ wages, among which 6 % is contributed by
employers’ payroll tax, and 2 % is contributed by the
employees themselves. For the URBMI, the annual pre-
mium in 2008 was on average 245 RMB for adults and
113 RMB for minors. In 2012, the annual NCMS pre-
mium was 300 RMB (made up of 240 RMB from central
and local governments, and 60 RMB from individuals).
Each scheme provides different levels of reimburse-
ment [8]. Better access to healthcare and risk protection
have been achieved through the expansion of insurance
coverage (reaching 95.7 % in 2011 [9]), and increase in
subsidies and benefits over time. Prior studies that have
evaluated disparities in health insurance generally fo-
cused on one scheme [10–13], and little is known about
the disparities among the different health insurance
schemes. Several studies have reported that families cov-
ered by the UEBMI or the URBMI had lower rates of
catastrophic health expenditure than those enrolled in
the NCMS, however, these studies were neither system-
atic nor specific [14]. The levels of reimbursement and
associated out-of-pocket (OOP) expenses related to a
given disease among the different health insurance
schemes have not been studied. The primary objective of
this study is to fill this evidence gap by examining dis-
parities in reimbursement for tuberculosis (TB) care
among the health insurance schemes in China.
Because TB is an infectious disease, it is ideal for this
study. China has the second largest TB burden in the
world [15] and the disease has long been on the govern-
mental agenda [16]. Considerable progress has been made
towards addressing the TB epidemic, however, TB treat-
ment costs remain a heavy financial burden on patients
[17, 18]. In China, treatment for TB is free in theory, but
studies show that there are many associated healthcare
costs, such as liver-protection drugs and extra diagnostic
tests, as well as considerable indirect costs [19–21].
As a key policy area for TB care and prevention [22, 23],
health insurance is an indispensable means of financial
protection [24]. Integrating the national TB control pro-
gram into health insurance schemes is an effective strategy
to address challenges in current China [25]. In China, TB
patients can receive anti-TB treatment in designated hos-
pitals through the coverage of the three health insurance
schemes. Expenses associated with TB treatment may be
partially covered by these schemes, however, patients are
responsible for any required deductibles and co-payments.
An evaluation of the disparity in reimbursements for TB
care among the health insurance schemes would inform
how to best design the reimbursement structure to ensure
both equity and efficiency in TB control.
This study extended previous studies by analyzing
reimbursement related to TB care among the above-
mentioned health insurance schemes. A claims database
analysis of all hospitalization reimbursed by the schemes
in Yichang city (YC), central China, covering 1506 dis-
charges, was conducted to identify differences in the total
inpatient expenses, OOP expenses and the effective reim-
bursement rate.
Methods
Study setting
According to a study published in The Lancet, the lowest
average inpatient reimbursement rates were reported in
China’s central region (41.2 %). Households in the cen-
tral region are vulnerable, with high rates of catastrophic
health spending. The percentage of households experi-
encing catastrophic health expenses was 13.7 % (13.3 %
in the west region and 11.9 % in the east region). In
2011, households in the central region spent an average
of 13.2 % of their annual expenditure on health (13.1 %
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in the west region and 12.4 % in the east region) [9]. For
this reason, this study focuses on the central region.
Located in central China and the middle reaches of
Yangtze River, the Hubei province had a gross domestic
product (GDP) per capita totaling RMB 34,131 in 2011,
which ranks it 13th among the 32 provinces (municipal-
ities and autonomous regions) in China’s mainland.
Yichang city, located in southwestern Hubei, had a GDP
per capita of RMB 56,265 in 2011. The China National
Health and Family Planning Commission (NHFPC)-Bill
& Melinda Gates Foundation TB Project has been widely
conducted in YC. The local governments were able and
willing to collaborate in this study. Given what mentioned
above, our study was designed to examine the disparity of
tuberculosis care reimbursement among different health
insurance schemes in YC, Hubei province.
A stratified random sampling procedure was used.
Three counties in YC were purposively selected to repre-
sent the entire city, in terms of socioeconomic develop-
ment and geographic conditions (hilly/plain): Yidu (YD),
Zhijiang (ZJ) and Wufeng (WF) were chosen as the study
counties. Yidu is the most developed county, whereas WF
is the most underdeveloped one, as shown in Table 1.
Data sources
Quantitative data were obtained primarily from the rou-
tine data systems of the UEBMI, the URBMI and the
NCMS, from their corresponding offices in each county.
To estimate the direct medical costs of and financial bur-
den on general TB patients in all study counties, informa-
tion managers extracted reimbursement data of inpatients
diagnosed with TB from January 2010 to December 2012.
Key variables included sex, age group and choice of health
providers, and hospitalization cost, reimbursement ex-
penses, non-reimbursable expenses relating to TB associ-
ated service provision. 1506 discharges were conducted,
including 1001 discharges of the NCMS, 348 of the
UEBMI and 157 of the URBMI.
All study counties were required to collect policy doc-
uments related to payment and reimbursements of TB
treatment costs.
Conceptual framework
Equity is widely considered a major objective of health-
care policies in international settings [26]. Generally, it
can be divided into three parts: health equity, financial
equity and utilization equity. Equity in health means
providing all population groups an equal opportunity to
be healthy [27, 28]. Financial equity plays a significant
role in promoting healthcare access and achieving uni-
versal coverage of health services, especially for the poor
and vulnerable groups [29]. It requires that healthcare
payments are determined fairly and based on a house-
hold’s ability to pay (ATP). The equity of utilization on
the other hand is judged using the concentration index,
as an individual’s need for health care isn’t reliant on in-
come [30]. Financial equity and utilization equity can be
defined in two dimensions: horizontal equity and vertical
equity. Horizontal equity means that equal access to
health care should be provided to people with the same
illness (equal treatment for equal needs) [31]. Vertical
equity means that people with the greatest needs are
given the most care [26]. The pursuit of equity is a pri-
mary objective of healthcare systems, and health insur-
ance is frequently cited as a key determinant of ensuring
equity as it lowers financial barriers and increases de-
mand for health care.
The World Health Report 2010 represented the concept
of universal health coverage (UHC) in three dimensions:
breadth, depth and height. Breadth refers to population
coverage, depth refers to the range of services covered,
and height refers to the extent to which costs associated
with health care are covered [14, 32]. This study will use
this framework to look into the disparities in reimburse-
ment for TB care among the three health insurance
schemes in China.
Data analysis
The NCMS operates at the county level. The UEBMI
and the URBMI are managed at multiple levels. Thus,
we made a comparison at the county level.
The quantitative data analysis was performed using
SPSS Statistics version 17.0. The main analysis used
descriptive statistics and focused on the associations
between health insurance, and the expenditure and re-
imbursement rates associated with TB-related services.
To measure the level of reimbursement related to TB
care, a number of things were considered, including OOP
expenses, the effective reimbursement rate (amount of
reimbursement/total expenditure on medical care), and
the non-reimbursable expenses rate (non-reimbursable
expenses/total expenditure on medical care). An ana-
lysis of the financial burden placed on patients was also
conducted by dividing the OOP expenses by the annual
average income per capita. Equity of access to TB care
among the three health insurance schemes was assessed,
disaggregated by project sites. Appropriate statistical
methods, including variance analysis, were employed for
the data analysis.
Table 1 Economic status in three counties in YC 2012
YD ZJ WF
GDP per capita (yuan) 89001 58630 23325
Urban annual income per capita (yuan) 19431 17465 12064
Rural annual income per capita (yuan) 10415 10496 4391
Data source: The economic indicators were obtained from statistical yearbook
in YC
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Health insurance policies were categorized and ana-
lyzed by region. The deductible, the reimbursement rate
and the ceiling level of multi-level hospitals were also
determined.
Quality assurance
Measures were taken to ensure the quality of the data
compiled. All the data collection instruments, tools and
procedures developed for the study were tested in a pilot
exercise in one project county. Following this exercise, a
workshop was held to discuss any problems and to iden-
tify what needed to be amended. A logic check of all
collected data was also done to identify gaps, inaccur-
acies and apparent incongruities and inconsistencies.
Missing data
Comprehensive data from the three health insurance
schemes for three years were included in the analysis, with
one exception from ZJ, where only data from NCMS for
the year 2012 were included in the analysis.
Ethical approval
Ethical approval was obtained from the Institutional
Ethics Committee, Chinese Center for Disease Control
and Prevention, China.
Results
Disparities in reimbursement for TB care among the three
health insurance schemes
Population: who is covered?
The three health insurance schemes have coverage of over
95 % of the total population in all three counties, as shown
in Table 2. All three schemes offer inpatient and out-
patient reimbursement for TB care in different forms.
The NCMS emphasizes coverage of TB inpatient ser-
vices [33] and hospitalization expenditures can be reim-
bursed with some co-payment. There are three modes of
outpatient reimbursement as part of the NCMS [34, 35]:
(1) household savings accounts, which can be used by
beneficiaries directly to pay for outpatient expenditures;
(2) outpatient reimbursement, which reimburses out-
patient fees up to a certain amount at county and/or
township level; and (3) outpatient reimbursement for
selected catastrophic or chronic illnesses, which com-
pensates for large outpatient expenditures by establish-
ing a catastrophic or chronic illness pooling fund. This
includes diseases that are expensive to treat, but don’t
necessarily require admission to hospital (e.g. nephropa-
thy, hepatitis, diabetes, hypertension). All three counties
adopt this three-level structure. Reimbursements for TB
outpatient care are available at township, village or com-
munity health facilities. Tuberculosis patients who have to
seek treatment in the county-level TB designated hospitals
cannot claim reimbursement for general outpatient care.
Because of this, the NCMS provides a package covering
chronic diseases, including TB, which means that TB
patients can claim reimbursement for outpatient care
accordingly (see Table 3).
The UEBMI consists of a pooled fund for inpatient stays
and individual medical savings accounts for outpatient
visits [36]. In terms of TB care, the UEBMI offers in-
patient and outpatient reimbursement for chronic diseases
(a similar structure to the NCMS).
The URBMI seeks to eliminate impoverishment caused
by high medical expenses by focusing on inpatient and
outpatient services for chronic and fatal diseases, such as
diabetes and heart disease [37]. Tuberculosis patients are
not covered by a package covering services for chronic
diseases, however, they can still claim for inpatient and
general outpatient reimbursement.
Services: which services are covered?
The NCMS offers a narrower benefit package than the
other two schemes. Eleven anti-TB drugs are included in
the NCMS, namely streptomycin, isoniazid, rifampicin,
ethambutol, aminosalicylate sodium, pyrazinamide, rifa-
pentine and rifamycin, among others, whereas 20 drugs
are covered by the UEBMI and the URBMI. Drugs are esti-
mated to account for just under half of a TB patient’s OOP
expenses [38]. A more inclusive drug reimbursement list
could help reduce TB patients’ OOP expenses by decreas-
ing non-reimbursable expenses. According to our data re-
sults related to TB inpatients, non-reimbursable expenses
rates for those covered by the NCMS from 2010 to 2012
in YD, ZJ and WF were 7.8, 13.34 and 5.8 %, respectively.
Costs: proportion of the costs covered
The ability of health insurance schemes to reduce the
financial burden of patients depends on the amount of
Table 2 Health insurance coverage in three counties in YC 2012
YD ZJ WF
NCMS coverage rate (%) 100 99 98
UEBMI coverage rate (%) 98 98 100
URBMI coverage rate (%) 98 99 96
Data source: Data were collected from the records of NCMS, UEBMI and
UEBMI offices
Table 3 Reimbursement policies of three health insurance
schemes for TB outpatient services
Health insurance
scheme
Inpatient
reimbursement
Outpatient reimbursement
General
outpatient
Chronic diseases
outpatient
NCMS √ × √
UEBMI √ × √
URBMI √ √ ×
Note: “√” indicates TB patients can enjoy the compensation policy and
vice versa
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funds that can be raised and pooled. Compared to the
UEBMI, the URBMI and the NCMS have low financing.
In YC city, for the NCMS, the annual premium per
person was RMB 290 in 2012; for the URBMI, it was
RMB 200; and for the UEBMI, it was usually over RMB
1000. Thus, the NCMS and URBMI have very basic bene-
fit packages, which means they don’t provide their benefi-
ciaries with adequate funds to alleviate the economic
hardships caused by serious diseases. Table 4 shows the
reimbursement rates for TB outpatient care among the
different health insurance schemes, by area.
Tuberculosis patients who are covered by the UEBMI
enjoy a more generous inpatient reimbursement policy,
as shown in Table 5. In this scheme, overall reimburse-
ment rates increase with medical expenses rather than
being determined by the level of the medical institution/
hospital where the patient sought treatment. The ceiling
is four times that of the average wage in the locality.
The NCMS reimbursement rates are higher than those
of the URBMI, but lower than those of the UEBMI. Re-
imbursement for TB inpatient services is the same as for
other inpatient services covered by the NCMS. The
higher the level of the medical institution in which a
patient receives treatment, the more he/she needs to pay
out of pocket. The ceiling level for reimbursement
ranged from RMB 100,000 to RMB 150,000.
The impact of disparities in reimbursement for TB care
among the different health insurance schemes
Tuberculosis patients have inadequate outpatient service
coverage because of limited funding, as shown in Table 4.
Databases from the health insurance schemes cannot fully
reflect the reimbursement rates of TB patients in the out-
patient setting. Problems in the design of the information
systems result in a lack of essential information about out-
patient services. Therefore, we focused on examining dispar-
ities in reimbursement for TB care in the inpatient setting.
Given the different economic development levels of the
counties and reimbursement levels of the schemes, we
analyzed the total inpatient expenses and OOP expenses
of patients enrolled in the three health insurance schemes
(see Table 6). Generally, total inpatient expenses for those
covered by the UEBMI were the highest. Inpatients cov-
ered by the URBMI had the highest OOP expenses. The
total inpatient expenses among the three health insurance
schemes can be illustrated as such: NCMS <URBMI <
UEBMI, with one exception in ZJ, where the total in-
patient expenses of patients covered by the NCMS were a
little higher than of those patients covered by the URBMI.
The OOP expenses among the three health insurance
schemes can be illustrated as such: UEBMI <NCMS <
URBMI, with an exception in ZJ, where it was URBMI <
NCMS. Finally, the effective reimbursement rate among
the three health insurance schemes can be illustrated as
such: UEBMI >URBMI >NCMS (see Fig. 1).
Table 4 Reimbursement of three health insurance schemes for
TB outpatient care in 2012
Health insurance
scheme
City/County Outpatient reimbursement
NCMS YD 200 yuan/year
ZJ 45 yuan/month with an annual
reimbursement cap of 540 yuan
WF 70 % of annual total costwith an annual
reimbursement cap of 2000 yuan
UEBMI YC reimbursement rate averages 75 %
within 200 yuan/month (6 months
for first treatment, 8 months for
retreatment)
URBMI YC 40 % of accumulated cost ranging from
50 to 400 yuan
Table 5 Deductible (in Yuan) and reimbursement rates
(percentages) by hospital type and health insurance type in YC
County Health
insurance
scheme
Deductible (Yuan) Reimbursement rate (%)
THC CH CHHL THC CH CHHL
YD NCMS 100 500 500 85 65 50–65
UEBMI — — — 85–95 85–95 85–95
URBMI 100 300 500 80 60 50
ZJ NCMS 100 300 300–500 85 75 50–65
UEBMI — — — 85–95 85–95 85–95
URBMI 100 300 500 80 60 50
WF NCMS 50 200 500 80 70 55–65
UEBMI — — — 85–95 85–95 85–95
URBMI 100 300 500 80 60 50
Note: Reimbursement rate of UEBMI varies with medical cost section instead of
hospital level
THC refers to “township health centers”
CH refers to “county hospitals”
“CHHL” refers to “city hospitals or higher level”
Data resource: Author’s data are collected from the records of NCMS, UEBMI
and UEBMI offices
Table 6 Total inpatient expense and OOP of TB inpatients in
three counties in YC 2012
Total inpatient expenses (Yuan) OOP (Yuan)
Mean Median Mean Median
YD NCMS 4522 3106 2397 1513
UEBMI 7371 4197 1895 1097
URBMI 5525 2964 2722 1489
ZJ NCMS 6372 4734 3048 1972
UEBMI 7583 4376 1634 1027
URBMI 6333 4190 2725 1729
WF NCMS 4818 3148 2078 1195
URBMI 11491 6443 3495 2121
Note: WF is a typical agricultural county with a smaller urban population, and
there were no TB patients with UEBMI
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We further analyzed patients’ choice of health providers
by health insurance scheme (see Table 7). Tuberculosis pa-
tients covered by the UEBMI could get almost equivalent
reimbursement rates in all medical institutions. The OOP
expenses of patients covered by the URBMI and NCMS
generally increased at higher levels of the referral system,
whereas reimbursement rates decreased according to the
policy design. We can conclude that the design of the
reimbursement policy had a significant impact on patients’
medical-seeking behavior.
To further estimate the financial burden placed on TB
patients covered by the different health insurance
schemes, we divided the OOP expenses by the annual
average income per capita. Shows that NCMS provided
modest financial protection, based on income. Generally,
the number calculated by dividing “OOP expenses by
the annual average income per capita” was higher in
poorer counties Fig. 2.
Discussion
To the best of our knowledge, limited research has been
conducted on the disparities in health insurance schemes.
Health disparities are a serious public health issue in the
USA [39], where insurance systems are decentralized. Sev-
eral studies have focused on insurance-related disparities
to determine whether there are differences in treatment
based on the insurance patients are covered by. By exam-
ining a single medical condition, several studies have
found that insurance status was associated with different
mortality outcomes and use of resources [40–43]. Hasan
et al. reported that patients covered by Medicare or pri-
vate insurance tend to receive higher-quality care than
those covered by Medicaid [44]. In a comparison of
quality of care delivered to patients in the same hospital,
Spencer et al. found that there are differences in quality of
health care provided to patients across different payer
types even within the same hospital [45]. Rashford et al.
also found that a single-payer system would cost less to
manage than a multi-payer system [46]. Using data from
the Fourth National Health Service Survey, one study
published in Chinese found that the populations covered
by the UEBMI had a higher benefit level and lower eco-
nomic burden than those covered by the URBMI or
NCMS [47]. The present study is the first in China to
compare the disparities in reimbursements for a given
disease among different health insurance schemes.
Therefore, this study can control the biases associated
with various types of illness and obtain more accurate
results. Three key findings emerge from this analysis,
which we discuss below.
Although TB patients covered by the three health in-
surance schemes suffer from the same illness, our study
showed that they have different inpatient expenses (TB
patients covered by the NCMS have less inpatient ex-
penses than those who were covered by the URBMI,
who have less inpatient expenses than those covered by
the UEBMI). This indicates a significant horizontal
inequity of healthcare utilization in the lower socioeco-
nomic groups. Those covered by the UEBMI had almost
equivalent reimbursement rates in all medical institu-
tions, thus they could seek medical care at higher level
medical institutions, which helps to ensure a relatively
high quality of medical care. Reimbursement levels for
patients covered by the URBMI and NCMS varied by
hospital type. In particular, TB patients covered by the
NCMS were disadvantaged in accessing TB inpatient
care, which is consistent with previous reports showing
how different types of health insurance programs affect
healthcare utilization outcomes among the elderly in
China [48]. There could be two reasons for this. First,
TB patients covered by the NCMS are usually from the
lower socioeconomic bracket. Second, TB patients covered
by the NCMS were located in rural areas and their access
Fig. 1 Effective reimbursement rates for TB inpatients in the three
study counties in 2012 (%)
Table 7 Number of discharges, mean OOP and effective reimbursement rate per hospitalization by health insurance scheme type in
YC City
Number (%) Mean OOP per hospitalization (Yuan) Effective reimbursement rate (%)
Township County Prefecture/Province Township County Prefecture/Province Township County Prefecture/Province
NCMS 161 (16.1) 515 (51.5) 325 (32.5) 355 1708 4655 75.1 57.7 45.2
UEBMI 9 (2.6) 237 (68.1) 102 (29.3) 554 1192 3177 76.3 75.5 77.3
URBMI 5 (3.3) 112 (73.2) 36 (23.5) 350 1802 5921 70.6 57.0 49.6
Note: The differences in mean OOP and effective reimbursement rate per hospitalization by health insurance scheme type were all significant at P < 0.05
according to analysis of variance
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to health care was usually hindered by poor transportation
services. Low incomes and inadequate reimbursement
rates also led to curtailed access. Tuberculosis patients
may not seek medical treatment because of financial issues
or incur catastrophic health expenses if they continue
treatment, both of which would hamper TB control [49].
Our study also revealed financial inequity among TB
patients. The prepayment structure of health insurance
schemes is supposed to shift funds from the rich to the
poor. But according to our results, TB patients who
earned less actually paid more.
Generally, TB patients are more likely to receive out-
patient treatment rather than seek inpatient services.
The NCMS and URBMI mainly cover reimbursement
for hospitalization, and their reimbursement structures
for TB outpatient services are not adequate, character-
ized by low ceilings and high co-insurance rates. The
UEBMI offered a more generous outpatient reimburse-
ment policy with a higher reimbursement rate and an
annual reimbursement cap. But it is still not sufficient.
Existing literature shows that low-income patients who
incur high costs for TB treatment have a poor adherence
for treatment, which leads to interrupted or suspended
treatment [50]. Given the inadequate outpatient reim-
bursement rates and the length of outpatient treatment, a
portion of poor TB patients may fail to complete their
treatment. Meanwhile, TB patients who have higher in-
comes may seek inpatient treatment that is reimbursed at
a higher rate, which results in a large number of hospitali-
zations and places a severe economic burden on patients.
The UEBMI provides comprehensive services for in-
sured TB inpatients, with higher reimbursement ra-
tios. Hence, TB patients covered by the UEBMI had
the highest effective reimbursement rate (exceeding
75 %) and the lowest mean OOP expenses (less than
RMB 2000). The URBMI and the NCMS provide nei-
ther adequate financial protection nor service cover-
age for TB patients. Taking income into account, TB
patients covered by the NCMS were particularly
vulnerable; their expense rates indicated a high risk
for catastrophic health spending. A large proportion
of the inpatient expenses had to be covered by the
individual or his/her family, which impairs affordable
and equitable access to health care and consequently
hampers TB control. Furthermore, TB patients cov-
ered by the NCMS usually have low ATP. The number
calculated by dividing OOP expenses by the annual aver-
age income per capita was significantly higher among
NCMS beneficiaries than among the UEBMI beneficiaries
who have higher ATP and it was not progressive to ATP,
suggesting that the worse off TB patients were required to
pay more out of pocket.
There are two alternative explanations for the financial
inequity among the different health insurance schemes.
First, the relatively low financing level results in a com-
paratively low level of compensation for medical expenses
[33, 51]. Second, the three health insurance schemes cover
specific groups: rural residents (under the NCMS), urban
employees (under the UEBMI), and unemployed urban
residents (under the URBMI). Generally, TB inpatients
who are covered by the URBMI or the NCMS are more
vulnerable and have lower ATP. They also often have poor
healthcare consciousness and access.
Prior studies have showed that a patient’s economic sta-
tus plays an important role in financial burden alleviation
[52, 53]. Our study also highlighted that TB patients in
poorer areas were more vulnerable. The number calcu-
lated by dividing OOP expenses by the annual average
income per capita decreased progressively with the eco-
nomic level of the studied counties. This relates to find-
ings from other studies, which found that poverty is both
a cause and a devastating outcome of TB [54]. Medical fi-
nancial assistance for the poor has been established in al-
most all regions of China. However, the criteria to be
eligible for this assistance are often very demanding and
most TB patients are not qualified to apply, unless specific
policies have been developed to meet their needs.
This study had several limitations, hence, the conclu-
sions drawn from this paper should be applied with cau-
tion. First, the sample size is relatively small. Only
samples from one city in central China were considered.
Second, previous studies concerning inequity are all
based on income groups of the study participants. Due
to the limitation of the information system, we couldn’t
gather information about the income of every TB patient
in this study. Instead, we made estimates using average
incomes, which may narrow the differences of income-
related equity among TB patients.
Conclusion
Our study had three major findings. First, there is a signifi-
cant horizontal inequity of healthcare utilization among TB
Fig. 2 Numbers calculated by dividing the OOP expenses by the
annual average income per capita in YC, by health insurance type
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patients from lower socioeconomic groups. Second, poorer
TB patients who are covered by the NCMS paid more out
of pocket. Third, TB patients in the lower socioeconomic
bracket were more vulnerable.
These findings have important policy implications, es-
pecially in the context of TB control, implementation of
health insurance schemes, and broader reforms of health
equity. Further priorities could focus on improving
healthcare equities in outcomes, controlling TB inpatient
costs and addressing major concerns about the benefit
packages of health insurance schemes.
First, an important implication is that the disparity in re-
imbursement for TB care among the different health in-
surance schemes would eventually hamper TB control.
Reducing the gap in health outcomes, i.e. reimbursement
rates, among the three health insurance schemes in China
should be a focus of TB care and control. Tuberculosis pa-
tients covered by the URBMI or the NCMS should be the
target population of future healthcare policies on TB.
This implication has an international significance.
First, our study provides a solution for how health insur-
ance schemes can be effective in TB control. According
to the WHO, in 2013, nine million people fell ill with TB
and 1.5 million died from the disease. Strategies are ur-
gently needed to end the global TB epidemic. Second,
UHC is an increasingly important global initiative. Our
study of the China experience showed large disparities
in reimbursement for TB care among the three health
insurance schemes in the three dimensions of UHC,
uncovering additional evidence about the impact of dif-
ferent health insurance benefit packages on TB health
service utilization. In addition, the distributional results
of health insurance expansion efforts could be enlighten-
ing, especially for countries with decentralized insurance
systems. In order to achieve UHC, measures should be
taken to improve health outcomes and tackle poverty by
narrowing gaps and increasing the coverage of different
health insurance schemes.
Second, inequity is a common challenge worldwide.
The present study reveals that there is inequity within
counties, which may provide useful lessons for countries
with decentralized insurance systems that face similar
challenges. In addition, this study indicates that inequity
could be reduced by tailoring health insurance policies.
As for China, given the differences in reimbursement
rates among the UEBMI, the URBMI and the NCMS,
achieving equity through integrated policies that avoid
discrimination is likely to be effective.
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